Swiss drugmaker Roche won clearance from Britain’s Competition and Markets Authority for its $4.3 billion takeover of gene therapy company Spark Therapeutics, the London Stock Exchange said on Monday, as a U.S. review continues.
Roche wins UK clearance for $4.3 billion Spark takeover as U.S. review continues